Splenic marginal zone lymphoma epidemiology and demographics
|
Splenic marginal zone lymphoma Microchapters |
|
Differentiating Splenic marginal zone lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Splenic marginal zone lymphoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Splenic marginal zone lymphoma epidemiology and demographics |
|
FDA on Splenic marginal zone lymphoma epidemiology and demographics |
|
CDC on Splenic marginal zone lymphoma epidemiology and demographics |
|
Splenic marginal zone lymphoma epidemiology and demographics in the news |
|
Blogs on Splenic marginal zone lymphoma epidemiology and demographics |
|
Directions to Hospitals Treating Splenic marginal zone lymphoma |
|
Risk calculators and risk factors for Splenic marginal zone lymphoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [4]
Overview
Epidemiology
Less than 1% of all lymphomas are splenic marginal zone lymphomas[1] and it is postulated that SMZL may represent a large fraction of unclasssifiable CD5- chronic lymphocytic leukemias.[2]The typical patient is over the age of 50, and gender preference has been described.[3]
References
- ↑ [1] Armitage JO, Weisenburger DD. "New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project." J Clin Oncol. 1998 Aug;16(8):2780-95. PMID: 9704731
- ↑ [2] Jaffe E.S., Harris N.L., Stein H., Vardiman J.W. (eds): World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of Haemopoietic and Lymphoid Tissues. IARC Press: Lyon 2001
- ↑ [3] Berger F, Felman P, Thieblemont C, Pradier T, Baseggio L, Bryon PA, Salles G, Callet-Bauchu E, Coiffier B. "Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients." Blood. 2000 Mar 15;95(6):1950-6. PMID: 10706860